Muscle biopsies of dermatomyositis and polymyositis patients demonstrate the presence of GLP-1R; GLP‐1R agonists ameliorated muscle weakness, muscle weight loss, and muscle inflammation through inhibiting muscle fiber necroptosis. This evidence concerns the gene GLP1R and dermatomyositis.